Abstract:Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disease characterized by thrombosis and/or pregnancy complications caused by antiphospholipid antibodies (aPL). The history of APS can be traced back to observations made during screening programs for syphilis conducted in the mid-20th century, with identification of patients with the so-called biological false-positive serological reactions for syphilis. Initial observation linking aPL with recurrent miscarriages was first reported more than 40 years ago. Since then, our understanding of the pathogenesis and management of APS has evolved markedly. Although APS is an autoimmune disease, anticoagulation mainly with vitamin K antagonists (VKAs) rather than immunomodulation, is the treatment of choice for thrombotic APS. Direct acting oral anticoagulants are inferior to VKAs, especially those with triple-positive APS and arterial thrombosis. Inflammation, complement activation, and thrombosis in the placenta may contribute to pathogenesis of obstetric APS. Heparin, mainly low-molecular-weight heparin, and low-dose aspirin represent the treatments of choice for women with obstetric complications. Increasingly, immunomodulatory agents such as hydroxychloroquine for thrombotic and obstetric APS are being used, especially in patients who are refractory to present standard treatment. Article published online: 16 January 2023 © 2023. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Nitroalcohol Induced Hydrogel Formation in Amine-Functionalized Polymers.

An update on inflammation in antiphospholipid syndrome

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

Rethinking antiphospholipid syndrome to guide future management and research

Obstetric Anti-phospholipid Syndrome: State of the Art

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases

Insights into Molecular Mechanisms and Clinical Manifestations

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms

New and upcoming treatments in antiphospholipid syndrome: A comprehensive review

Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome

New advances in genomics and epigenetics in antiphospholipid syndrome

Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy.

Women's Issues in Antiphospholipid Syndrome

Evolution of Antiphospholipid Syndrome

Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder

Obstetric Antiphospholipid Syndrome: An Update on Pathophysiology and Management

Antiphospholipid Syndrome: a Clinical Perspective

Review of Antiphospholipid Syndrome and Its Cardiovascular Manifestation